These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Efficacy and safety of a single oral 150 mg dose of fluconazole for the treatment of vulvovaginal candidiasis in Japan. Mikamo H; Matsumizu M; Nakazuru Y; Okayama A; Nagashima M J Infect Chemother; 2015 Jul; 21(7):520-6. PubMed ID: 25887336 [TBL] [Abstract][Full Text] [Related]
6. Severe cutaneous adverse drug reaction due to fluconazole. Lester LJ; Brantley JS; Kelso RL; Kelly BC; Petitt MS; Wilkerson MG J Drugs Dermatol; 2008 Nov; 7(11):1084-7. PubMed ID: 19110744 [TBL] [Abstract][Full Text] [Related]
8. [Comparison of clinical efficacy and safety of domestic generic and original fluconazoles in the treatment of pregnant women with vulvovaginal candidiasis]. Pikuza VV; Chilova RA; Ishchenko AI Antibiot Khimioter; 2008; 53(7-8):35-7. PubMed ID: 19227122 [No Abstract] [Full Text] [Related]
9. A clinical multicenter study comparing efficacy and tolerability of topical combination therapy with clotrimazole (Canesten, two formats) with oral single dose fluconazole (Diflucan) in vulvovaginal mycoses. Mendling W; Krauss C; Fladung B Mycoses; 2004 Apr; 47(3-4):136-42. PubMed ID: 15078430 [TBL] [Abstract][Full Text] [Related]